Reaction profile

The FDA adverse-event record for burn

120 FDA adverse-event reports reference burn (VeDDRA 926). Plate codes and volume neighbourhood below; species, breeds, and drugs follow.

#1301 of 2,481
by report volume (all reactions)
120
reports citing this reaction
2.5%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Burn has 120 reports now versus 118 in that prior snapshot: 2 more (1.7%).

Report change
+2
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Burn changes

FDA AER · VeDDRA plate

Code 926 VOL-LOW

VOL-LOW · DEATH-LOW · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-LOW 120 reports
  • DEATH-LOW 2.5%
  • MID-PACK #1301/2481
  • PHOTO-FINISH Breathlessness
  • SPECIES-DOG Dog · 58
  • DRUG-LEAD Carprofen · 15
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Breathlessness (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Report-volume neighbourhood around Burn

Highest and lowest poles plus nearest volume peers, not a full 2,500-reaction corpus board reprint.

Vomiting · highest174348Breathlessness · near120Burn · this reaction120Groaning · near120Neck pain - neurologi… · near120Reduced food intake · near120Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Burn

Burn: low death-coded share in the FDA AER plate

Signature read: Burn's 2.5% death-coded share is among the lowest in the openFDA reaction corpus. Report volume sits in the middle third of the reaction corpus. Death-coded share is lower-third: 3 of 120 reports (2.5% of named reports). Nearest volume peer: Breathlessness (±0 reports). Lead species Dog (58). Lead co-reported drug Carprofen (15).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Carprofen appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 58
Cat 33
Human 11
Horse 6
Unknown 6
Cattle 4
Chicken 1
Other Mammals 1

Breeds Most Affected

Unknown 20
Domestic Shorthair 14
Dog (unknown) 14
Cat (other) 9
Retriever - Labrador 7
Cat (unknown) 4
Horse (unknown) 3
Quarter Horse 2
Domestic Longhair 2
Perro de Presa Canario 2

Associated Drugs

Carprofen 15
Device: Surgical Instruments 12
Device: Electrosurgery 11
Selamectin 9
Isoflurane 9
Propofol 9
Selamectin;Sarolaner 9
Cefovecin 8
Maropitant Citrate 7
Buprenorphine 5
Meloxicam 5
Gabapentin 4
Fluralaner Spot-On Solution 4
Hydromorphone 4
Atropine 4
Prednisone 3
Ivermectin 3
Enrofloxacin 3
Milbemycin Oxime + Spinosad 3
Moxidectin 3

Nationwide reactions with similar profiles

Two openFDA-derived peer sets for Burn, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).

Similar report volume

Nearest other reactions by FDA report count (120 here).

Similar death-coded share

Nearest other reactions by death-coded share (2.5% here), distinct from the volume row.

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Burn (#1301 of 2,481 by report volume); death-coded 2.5%. PlainBreed reaction plate · death-coded share stamp 2.5% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →